First Ebola vaccine moves closer to licensing, with help of UF researchers
UF biostatisticians played an integral role in the design and analysis of trials testing the effectiveness of the vaccine.
UF biostatisticians played an integral role in the design and analysis of trials testing the effectiveness of the vaccine.
They will be honored at a ceremony during the college’s alumni reunion on October 5.
Experimental vaccine trials during a public health emergency should be novel, flexible and responsive, say a group of researchers led by UF biostatistics faculty. Photo: WHO
Seven faculty members were awarded tenure or promotion from the University of Florida for the 2018-19 cycle.
UF researchers combined a prospective cohort study of children in Nicaragua with epidemiological surveillance data to infer the complete exposure history for each participant. Photo: CDC
Researchers in the department of biostatistics will develop innovative vaccine study designs so agencies can implement vaccine trials quickly and effectively.
A mathematical model developed by Dr. Ira Longini and colleagues suggests that current approaches to cholera control and elimination are unlikely to solve the problem.
UF researchers have developed a model mapping the spread of Zika virus and the number of microcephaly cases that will occur by the end of the year. Photo: James Gathany/CDC
Dr. Ira Longini, a professor of biostatistics in the College of Public Health and Health Professions and the College of Medicine, is one of 34 UF scientists recognized for a distinguished record of research.
Drs. J. Glenn Morris and Ira Longini made up part of an international committee convened to recommend strategies to limit the risk of major new cholera epidemics following Hurricane Matthew.